Literature DB >> 22363140

Glycyrrhizin attenuates HMGB1-induced hepatocyte apoptosis by inhibiting the p38-dependent mitochondrial pathway.

Geum-Youn Gwak1, Tae Gun Moon, Dong Ho Lee, Byung Chul Yoo.   

Abstract

AIM: To examine how high-mobility group box 1 (HMGB1) regulates hepatocyte apoptosis and, furthermore, to determine whether glycyrrhizin (GL), a known HMGB1 inhibitor, prevents HMGB1-induced hepatocyte apoptosis.
METHODS: A human hepatocellular carcinoma cell line stably transfected with a bile acid transporter (Huh-BAT cells), were used in this study. Apoptosis was quantified using 4',6-diamidino-2-phenylindole dihydrochloride staining and the APO Percentage apoptosis assay, and its signaling cascades were explored by immunoblot analysis. Kinase signaling was evaluated by immunoblotting and by using selective inhibitors. It is also tried to identify hepatocyte apoptosis affected by the HMGB1 inhibitor, GL.
RESULTS: HMGB1 increased cellular apoptosis in Huh-BAT cells. HMGB1 led to increased cytochrome c release from mitochondria into the cytosol, and induced the cleavage of procaspase 3. However, it did not affect the activation of caspase 8. HMGB1-induced caspase 3 activation was significantly attenuated by the p38 inhibitor SB203580. GL significantly attenuated HMGB1-induced hepatocyte apoptosis. GL also prevented HMGB1-induced cytochrome c release and p38 activation in Huh-BAT cells.
CONCLUSION: The present study demonstrated that HMGB1 promoted hepatocyte apoptosis through a p38-dependent mitochondrial pathway. In addition, GL had an anti-apoptotic effect on HMGB1-treated hepatocytes.

Entities:  

Keywords:  Apoptosis; Glycyrrhizin; Hepatocyte; High-mobility group box 1; Mitochondria; p38

Mesh:

Substances:

Year:  2012        PMID: 22363140      PMCID: PMC3281226          DOI: 10.3748/wjg.v18.i7.679

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

Review 1.  Death receptor-mediated apoptosis and the liver.

Authors:  Jung-Hwan Yoon; Gregory J Gores
Journal:  J Hepatol       Date:  2002-09       Impact factor: 25.083

Review 2.  Adult neuron survival strategies--slamming on the brakes.

Authors:  Susanna C Benn; Clifford J Woolf
Journal:  Nat Rev Neurosci       Date:  2004-09       Impact factor: 34.870

Review 3.  Mitogen-activated protein kinases in apoptosis regulation.

Authors:  Teiji Wada; Josef M Penninger
Journal:  Oncogene       Date:  2004-04-12       Impact factor: 9.867

Review 4.  High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function.

Authors:  M Bustin; R Reeves
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1996

5.  Autoantibodies to nonhistone chromosomal proteins HMG-1 and HMG-2 in sera of patients with juvenile rheumatoid arthritis.

Authors:  B Wittemann; G Neuer; H Michels; H Truckenbrodt; F A Bautz
Journal:  Arthritis Rheum       Date:  1990-09

6.  High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis.

Authors:  R Kokkola; E Sundberg; A-K Ulfgren; K Palmblad; J Li; H Wang; L Ulloa; H Yang; X-J Yan; R Furie; N Chiorazzi; K J Tracey; U Andersson; H Erlandsson Harris
Journal:  Arthritis Rheum       Date:  2002-10

7.  Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis.

Authors:  M J Bussemakers; W J van de Ven; F M Debruyne; J A Schalken
Journal:  Cancer Res       Date:  1991-01-15       Impact factor: 12.701

8.  Characterization of cell lines established from human hepatocellular carcinoma.

Authors:  J G Park; J H Lee; M S Kang; K J Park; Y M Jeon; H J Lee; H S Kwon; H S Park; K S Yeo; K U Lee
Journal:  Int J Cancer       Date:  1995-07-28       Impact factor: 7.396

9.  Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.

Authors:  H Nakabayashi; K Taketa; K Miyano; T Yamane; J Sato
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

10.  Therapeutic basis of glycyrrhizin on chronic hepatitis B.

Authors:  H Sato; W Goto; J Yamamura; M Kurokawa; S Kageyama; T Takahara; A Watanabe; K Shiraki
Journal:  Antiviral Res       Date:  1996-05       Impact factor: 5.970

View more
  23 in total

Review 1.  Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?

Authors:  Moon-Sun Kim; Madeleine Ong; Xianqin Qu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 2.  Role of high-mobility group box 1 protein in inflammatory bowel disease.

Authors:  Zhen Hu; Xiaoyun Wang; Lei Gong; Gaojue Wu; Xiaobin Peng; Xuejun Tang
Journal:  Inflamm Res       Date:  2015-06-16       Impact factor: 4.575

3.  Selective inhibition of histone deacetylase 6 promotes survival in a rat model of hemorrhagic shock.

Authors:  Zhigang Chang; Yongqing Li; Wei He; Baoling Liu; Ihab Halaweish; Ted Bambakidis; Yingjian Liang; Hasan B Alam
Journal:  J Trauma Acute Care Surg       Date:  2015-12       Impact factor: 3.313

4.  Glycyrrhizic acid inhibits apoptosis and fibrosis in carbon-tetrachloride-induced rat liver injury.

Authors:  Bo Liang; Xiao-Ling Guo; Jing Jin; Yong-Chun Ma; Zheng-Quan Feng
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

5.  Glycyrrhizin protects rat heart against ischemia-reperfusion injury through blockade of HMGB1-dependent phospho-JNK/Bax pathway.

Authors:  Chang-lin Zhai; Mei-qi Zhang; Yun Zhang; Hong-xia Xu; Jing-min Wang; Gui-peng An; Yuan-yuan Wang; Li Li
Journal:  Acta Pharmacol Sin       Date:  2012-10-15       Impact factor: 6.150

6.  Glycyrrhizin ameliorates metabolic syndrome-induced liver damage in experimental rat model.

Authors:  Rajarshi Sil; Doel Ray; Abhay Sankar Chakraborti
Journal:  Mol Cell Biochem       Date:  2015-09-23       Impact factor: 3.396

7.  Glycyrrhizic acid attenuates CCl₄-induced hepatocyte apoptosis in rats via a p53-mediated pathway.

Authors:  Xiao-Ling Guo; Bo Liang; Xue-Wei Wang; Fu-Gang Fan; Jing Jin; Rui Lan; Jing-Hui Yang; Xiao-Chun Wang; Lei Jin; Qin Cao
Journal:  World J Gastroenterol       Date:  2013-06-28       Impact factor: 5.742

8.  MicroRNA-142-3p inhibits proliferation and induces apoptosis by targeting the high-mobility group box 1 via the Wnt/β-catenin signaling pathway in glioma.

Authors:  Chong Li; Shiyu Feng; Ling Chen
Journal:  Int J Clin Exp Pathol       Date:  2018-09-01

9.  Herbal products: benefits, limits, and applications in chronic liver disease.

Authors:  Anna Del Prete; Antonella Scalera; Maddalena Diana Iadevaia; Agnese Miranda; Claudio Zulli; Laura Gaeta; Concetta Tuccillo; Alessandro Federico; Carmelina Loguercio
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-06       Impact factor: 2.629

10.  Glycyrrhizin protects against porcine endotoxemia through modulation of systemic inflammatory response.

Authors:  Wei Wang; Feng Zhao; Yong Fang; Xiantao Li; Lei Shen; Tongwa Cao; Hechen Zhu
Journal:  Crit Care       Date:  2013-03-11       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.